Related references
Note: Only part of the references are listed.Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
Kristin B. Dupre et al.
EXPERIMENTAL NEUROLOGY (2011)
Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice
Mattia Volta et al.
JOURNAL OF NEUROCHEMISTRY (2010)
l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia
Hanna S. Lindgren et al.
JOURNAL OF NEUROCHEMISTRY (2010)
SITE-SPECIFIC ACTION OF L-3,4-DIHYDROXYPHENYLALANINE IN THE STRIATUM BUT NOT GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA EVOKES DYSKINETIC MOVEMENTS IN CHRONIC L-3,4-DIHYDROXYPHENYLALANINE-TREATED 6-HYDROXYDOPAMINE-LESIONED RATS
K. Buck et al.
NEUROSCIENCE (2010)
ENDOGENOUS NOCICEPTIN/ORPHANIN FQ (N/OFQ) CONTRIBUTES TO HALOPERIDOL-INDUCED CHANGES OF NIGRAL AMINO ACID TRANSMISSION AND PARKINSONISM: A COMBINED MICRODIALYSIS AND BEHAVIORAL STUDY IN NAIVE AND NOCICEPTIN/ORPHANIN FQ RECEPTOR KNOCKOUT MICE
O. S. Mabrouk et al.
NEUROSCIENCE (2010)
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors
Helen S. Bateup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA-Induced Dyskinesia and Histone Activation
Sanja Darmopil et al.
BIOLOGICAL PSYCHIATRY (2009)
An Ultra-Short Dopamine Pathway Regulates Basal Ganglia Output
Fu-Wen Zhou et al.
JOURNAL OF NEUROSCIENCE (2009)
Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
Daniella Rylander et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Rodent models of treatment-induced motor complications in Parkinson's disease
M. Angela Cenci et al.
PARKINSONISM & RELATED DISORDERS (2009)
Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
Emanuela Santini et al.
SCIENCE SIGNALING (2009)
In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats
Sophie Sarre et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism
Martina Fantin et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism
Riccardo Viaro et al.
NEUROBIOLOGY OF DISEASE (2008)
Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: Behavioural and biochemical evidence
Anna R. Carta et al.
PARKINSONISM & RELATED DISORDERS (2008)
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways
Martina Fantin et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
Emanuela Santini et al.
JOURNAL OF NEUROSCIENCE (2007)
Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat
S. Breit et al.
EXPERIMENTAL NEUROLOGY (2007)
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
Andrzej Dekundy et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease
Flora Mela et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway
Matteo Marti et al.
JOURNAL OF NEUROSCIENCE (2007)
Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism
Anne-Sophie Rolland et al.
BRAIN (2007)
Modulation of human motor cortex excitability by single doses of amantadine
Janine Reis et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats
M Carta et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease
M Marti et al.
JOURNAL OF NEUROSCIENCE (2005)
Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia
N Lundblad et al.
EXPERIMENTAL NEUROLOGY (2005)
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block
TA Blanpied et al.
JOURNAL OF NEUROSCIENCE (2005)
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease
PA Löschmann et al.
EXPERIMENTAL NEUROLOGY (2004)
The origin of motor fluctuations in Parkinson's disease - Importance of dopaminergic innervation and basal ganglia circuits
JA Obeso et al.
NEUROLOGY (2004)
Persistent increase in olfactory type G-protein α subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease
JC Corvol et al.
JOURNAL OF NEUROSCIENCE (2004)
Neurokinin-1 receptors in the rat nucleus tractus solitarius: Pre- and postsynaptic modulation of glutamate and GABA release
CP Bailey et al.
NEUROSCIENCE (2004)
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad et al.
NEUROBIOLOGY OF DISEASE (2004)
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
E Bézard et al.
NATURE MEDICINE (2003)
Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats
A Arai et al.
BRAIN RESEARCH (2003)
The frequency and significance of 'striatal toe' in parkinsonism
AS Winkler et al.
PARKINSONISM & RELATED DISORDERS (2002)
Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses
AE Stacey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo:: opposite role for D1 and D2 receptors
M Marti et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice
HL Liu et al.
BRAIN RESEARCH (2002)
Animal models of neurological deficits: how relevant is the rat?
MA Cenci et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias
F Calon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats
N Jonkers et al.
BRAIN RESEARCH (2002)
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
M Lundblad et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease
JD Oh et al.
AMINO ACIDS (2002)
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
CS Lee et al.
BRAIN (2000)
Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-D-aspartate receptors
K Steece-Collier et al.
EXPERIMENTAL NEUROLOGY (2000)
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
T Schallert et al.
NEUROPHARMACOLOGY (2000)
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease
JE Nash et al.
EXPERIMENTAL NEUROLOGY (2000)